All Stories

  1. From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer [Erratum]

    Article • International Journal of Nanomedicine, December 2018, Dove Medical Press

    joseph ciccolini

  2. Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles

    Article • Expert Opinion on Drug Metabolism & Toxicology, October 2018, Taylor & Francis

    joseph ciccolini

  3. From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer

    Article • International Journal of Nanomedicine, October 2018, Dove Medical Press

    joseph ciccolini

  4. Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

    Article • International Journal of Nanomedicine, June 2018, Dove Medical Press

    joseph ciccolini

  5. Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?

    Article • Clinical Cancer Drugs, January 2018, Bentham Science Publishers

    joseph ciccolini

  6. Preventive DPD deficiency testing helps to reduce 5-FU toxicities

    Article • Clinical Cancer Drugs, January 2018, Bentham Science Publishers

    joseph ciccolini

  7. Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs

    Article • Expert Opinion on Drug Metabolism & Toxicology, December 2014, Informa Healthcare

    joseph ciccolini

  8. Selection of the Best Blood Compartment to Measure Cytidine Deaminase Activity to Stratify for Optimal Gemcitabine or Cytarabine Treatment

    Article • Nucleosides Nucleotides & Nucleic Acids, April 2014, Taylor & Francis

    Professor Godefridus J Peters, joseph ciccolini